News

Study shows 12% retained sight for driving and 15% for reading.

Across the world, almost everyone has experienced a bad headache and knows the unpleasant symptoms that can come with it. Many have also faced migraines, which can cause dizziness, nausea and stomach pain - as well as impacting your vision.

In order to navigate the new landscape COVID-19 has brought along with it and connect with consumers who may be feeling confused and stressed out, lesser-known health insurers will need to introduce themselves to this new audience.

What does it mean? When did it begin? How is it different from public health? Here are the answers to these questions and more.

"Primary care as we know it today stands in the crosshairs, with new entrants vying for the hearts of consumers," says Forrester Research report. Telehealth and retail health clinics are among the suitors.

Pfizer, Moderna executives say efficacy, safety data won't be ready till well after Election Day. FDA's COVID-19 vaccine meeting on Thursday says sure to draw a big crowd.

William Trombatt and James Adams of AllianceRx Walgreens Prime discussed specialty pharmacy for people with MS at PBMI Specialty Rx Forum last week. The need for "higher touch" programs is important for people with MS, said Adams.

Managed Healthcare Executive's October issue headlines 10 chosen healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

Venclexta was previously granted provisional approval by FDA in late 2018.

The pharma maker plans to apply for FDA Emergency Use Authorization for the vaccine after the third week of November.

Managed Healthcare Executive's October issue headlines 10 chosen healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

Prior authorization and other utilization management strategies may cause harmful delays in therapy in oncology and for diseases such as multiple sclerosis, say panelists at PBMI's 4th Annual Specialty Rx Forum.

Next month voters will weigh in on issues including dialysis centers, abortion, legalization of marijuana.

FDA offers new options in classical Hodgkin lymphoma, and a warning for pregnant women about common pain relievers.

Preparing for a future that includes telehealth means considering revenue streams, ROI, facility planning and other factors.

Sanofi and Regeneron report positive Phase 3 results for Dupixent in children with moderate-to-severe asthma

How COVID-19 is affecting those specifically with chronic conditions and how technology is helping.

Reporters at ProPublica, The Wall Street Journal and Science have written in-depth accounts of CDC's faded role, damaged reputation and White House interference.

Francois de Brantes, Otis Brawley, Eric C. Hunter, Keely Macmillan, Ateev Mehrotra, and Marc Samuels are joining the Managed Healthcare Executive® editorial advisory board.

The Johns Hopkins professor and new MHE editorial advisory board member lauds the effects of the Affordable Care Act but holds out for a program that “gets every human being the healthcare that every human being deserves,” in this second part of a four-part series.

Featured speaker at the 4th Annual PBMI Specialty Rx Forum on October 16 discusses theme of the meeting.

In this week's episode of Tuning Into The C-Suite, MHE's Briana Contreras spoke with Kate Ryder, CEO of Maven, which is the world’s largest virtual clinic for women’s and family health. In this discussion, they talked about the role of telemedicine in pregnancy care, how it impacts the prenatal model and how it will influence the patient journey post-coronavirus pandemic.

Flu increases the risk of heart attack, especially among people with diabetes and atherosclerotic cardiovascular disease (ASCVD). COVID-19 and the possibility of co-infection makes getting vaccinated against the flu particularly important this year.

Darnell Dent, principal of Dent Advisory Services and a member of the Managed Healthcare Executive® Editorial Advisory Board, discusses health disparities for people of color - specifically Blacks and Latinos - and how COVID-19 has highlighted our failure at the intersection of public health, healthcare and social justice.

Sodium glucose co-transporter 2 (SGLT2) inhibitors have already remade the diabetes drug market. Now competition for new cardiac and renal indications is heating up among three of the main drugs in the class: Janssen’s Invokana (canagliflozin), AstraZeneca’s Farxiga (dapagliflozin), and Eli Lilly/Boehringer-Ingelheim’s Jardiance (empagliflozin).

Emergency use authorization granted for CareStart point-of-care kit.

Some “don’t give a damn about their fellow man.” But in this first of four-part video series, the Johns Hopkins professor, former chief medical and scientific officer of the American Cancer Society, and MHE Editorial Advisory Board member is encouraged by diversity among protestors and the broadening of the efforts to tackle disparities of all kinds. “I think this is a long-term effort.”

The pharma maker aims to make the treatment available to the most vulnerable populations by December.

Simponi Aria is now approved to to treat patients 2 years and older with active polyarticular juvenile Idiopathic arthritis (pJIA) and psoriatic arthritis (PsA).

Johnson & Johnson pauses trial, Pfizer wants to enroll teens, and fewer Americans are willing to be vaccinated. Here's a roundup of today's news about COVID-19 vaccines.